About OxSyBio
OxSyBio is a company based in London (United Kingdom) founded in 2014 by John Hagan Pryce Bayley.. OxSyBio has raised $16.35 million across 3 funding rounds from investors including IP Group, Woodford Investment Management and Parkwalk. The company has 285 employees as of March 31, 2024. OxSyBio operates in a competitive market with competitors including Nuclera Nucleics, Aspect Biosystems, CELLINK, Collplant and Triastek, among others.
- Headquarter London, United Kingdom
- Employees 285 as on 31 Mar, 2024
- Founders John Hagan Pryce Bayley
- Stage Minicorn
-
Sectors
HealthcareTechnology
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name James And James Fulfilment Ltd
- Date of Incorporation 12 Feb, 2010
- Jurisdiction NORTHAMPTON, ENGLAND
-
Annual Revenue
$44.8 M (USD)31as on Dec 31, 2022
-
Net Profit
$-983.33 K (USD)-129as on Dec 31, 2022
-
EBITDA
$-1.51 M (USD)-143as on Dec 31, 2022
-
Total Equity Funding
$16.35 M (USD)
in 3 rounds
-
Latest Funding Round
$13.87 M (USD), Series A
Feb 14, 2018
-
Investors
IP Group
& 2 more
-
Employee Count
285
as on Mar 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of OxSyBio
OxSyBio has successfully raised a total of $16.35M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $13.87 million completed in February 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series A — $13.9M
-
First Round
First Round
(22 Apr 2014)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2018 | Amount | Series A - OxSyBio | Valuation | Woodford Investment Management | |
| Nov, 2015 | Amount | Seed - OxSyBio | Valuation |
investors |
|
| Apr, 2014 | Amount | Seed - OxSyBio | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in OxSyBio
OxSyBio has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include IP Group, Woodford Investment Management and Parkwalk. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Tech companies are invested in by Parkwalk venture capital firm.
|
Founded Year | Domain | Location | |
|
Venture capital and advisory services are offered across multiple sectors.
|
Founded Year | Domain | Location | |
|
Diversified investment portfolios are managed for clients by the firm.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by OxSyBio
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - OxSyBio
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Oxsybio Comparisons
Competitors of OxSyBio
OxSyBio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Nuclera Nucleics, Aspect Biosystems, CELLINK, Collplant and Triastek, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Desktop bioprinter for genes and proteins production is developed.
|
|
| domain | founded_year | HQ Location |
Bioprinting technology and tissue therapeutics for regenerative medicine are developed.
|
|
| domain | founded_year | HQ Location |
3D bioprinters and bioinks are developed for research applications.
|
|
| domain | founded_year | HQ Location |
Plant-derived collagen is developed for tissue repair and 3D bioprinting.
|
|
| domain | founded_year | HQ Location |
Provider of 3D printing pharmaceutical technology platform for drug design
|
|
| domain | founded_year | HQ Location |
4D bio-printer solutions for tissue regeneration are provided.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Oxsybio
Frequently Asked Questions about OxSyBio
When was OxSyBio founded?
OxSyBio was founded in 2014.
Where is OxSyBio located?
OxSyBio is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Is OxSyBio a funded company?
OxSyBio is a funded company, having raised a total of $16.35M across 3 funding rounds to date. The company's 1st funding round was a Seed of $1.68M, raised on Apr 22, 2014.
How many employees does OxSyBio have?
As of Mar 31, 2024, the latest employee count at OxSyBio is 285.
What is the annual revenue of OxSyBio?
Annual revenue of OxSyBio is $44.8M as on Dec 31, 2022.
What does OxSyBio do?
Provider of 3D printing of tissue biomaterials for medical research and clinical applications. Its 3D printer claims to produce a range of tissue-like and functional tissues which claim to aid in testing drugs and, eventually structures for use in surgical repair. It is also planning to include living cells in the tissue-like materials and to refine the printer so it can produce even more complex structures, enabling the creation of living tissue samples.
Who are the top competitors of OxSyBio?
OxSyBio's top competitors include Nuclera Nucleics, Aspect Biosystems and Allevi.
Who are OxSyBio's investors?
OxSyBio has 3 investors. Key investors include IP Group, Woodford Investment Management, and Parkwalk.
What is OxSyBio's valuation?
The valuation of OxSyBio is $22.65M as of Feb 2018.